| 17-May-13 08:38AM | Company News for May 17, 2013 Zacks |
| 16-May-13 05:50PM | Derma Sciences' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 05:06PM | Derma Sciences Increases Sales but Misses Estimates on Earnings at Motley Fool |
| 12:27PM | Derma Sciences takes bigger 1Q loss as costs grow AP |
| 11:00AM | Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:35AM | InPlay: Derma Sciences beats on bottom line, misses on top Briefing.com |
| 07:34AM | Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:30AM | Derma Sciences Reports First Quarter 2013 Financial Results Business Wire |
| 07:07AM | Q1 2013 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN |
| 15-May-13 09:45AM | DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online +7.10% |
| 14-May-13 07:33AM | InPlay: Derma Sciences engages Plexus Ventures to explore strategic options for DSC127 Outside the U.S. Briefing.com |
| 07:32AM | Derma Sciences to explore strategic options for DSC127 outside U.S. theflyonthewall.com |
| 07:30AM | Derma Sciences Engages Plexus Ventures to Explore Strategic Options for DSC127 Outside the U.S. Business Wire |
| 08-May-13 08:23AM | Insiders Opting In at Seeking Alpha |
| 07-May-13 07:30AM | Derma Sciences to Hold First Quarter Financial Results Conference Call on May 16th Business Wire |
| 30-Apr-13 06:03PM | Nasdaq stocks posting largest volume increases AP |
| 29-Apr-13 06:06PM | Nasdaq stocks posting largest volume increases AP +5.03% |
| 26-Apr-13 06:05PM | Nasdaq stocks posting largest volume increases AP |
| 25-Apr-13 06:03PM | Nasdaq stocks posting largest volume increases AP |
| 04:02PM | InPlay: Derma Sciences begins screening patients in second Phase 3 trial with DSC127 for healing diabetic foot ulcers Briefing.com |
| 04:01PM | Derma Sciences Begins Screening Patients in Second Phase 3 Trial with DSC127 for Healing Diabetic Foot Ulcers Business Wire |
| 22-Apr-13 03:13PM | Derma Sciences to Present at the 12th Annual Needham Healthcare Conference Business Wire |
| 01:36PM | Derma Sciences to Present at Taglich Brothers 10th Annual Small Cap Equity Conference GlobeNewswire |
| 19-Apr-13 08:30PM | Faruqi & Faruqi, LLP Launches an Investigation against Derma Sciences, Inc. (DSCI) for Potential Breaches of Fiduciary Duties by Its Board of Directors Business Wire |
| 03-Apr-13 01:04PM | DERMA SCIENCES, INC. Financials EDGAR Online Financials |
| 02-Apr-13 01:02PM | Derma Sciences Beats Up on Analysts Yet Again at Motley Fool |
| 09:02AM | Company News for April 2, 2013 Zacks |
| 07:59AM | Derma Sciences' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 01-Apr-13 11:00AM | Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN |
| 09:07AM | DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 07:34AM | Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:10AM | Derma Sciences Expands TCC-EZ® Market Reach with Long-Term Exclusive Global Rights Agreement Business Wire |
| 07:00AM | Derma Sciences Reports 2012 Fourth Quarter and Full Year Financial Results Business Wire |
| 30-Mar-13 07:12AM | Derma Sciences Earnings Preview: Get Ahead of the Analysts at Wall St. Cheat Sheet |
| 28-Mar-13 10:23AM | DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 19-Mar-13 01:04AM | Some Numbers at Derma Sciences that Make Your Stock Look Good at Motley Fool |
| 01:04AM | Derma Sciences Passes This Key Test at Motley Fool |
| 15-Mar-13 04:44PM | Derma Sciences Announces Timing for Fourth Quarter Conference Call and 2012 Form 10-K Filing Business Wire |
| 14-Mar-13 12:17PM | Derma Sciences to Present at the 25th Annual ROTH Conference Business Wire |
| 14-Feb-13 03:17PM | 2 Fast Growing Wound Care Companies With Upcoming Milestones at Seeking Alpha |
| 06-Feb-13 11:46PM | 4 Healthcare Stock Stories for Investment Wellness at Wall St. Cheat Sheet |
| 08:00AM | Derma Sciences Initiates Enrollment in DSC127 Phase 3 Trial for Healing Diabetic Foot Ulcers Business Wire |
| 27-Jan-13 05:10PM | Did Derma Sciences Squander Its Latest Sales Increase? at Motley Fool |
| 17-Jan-13 09:04AM | Has Derma Sciences Made You Any Fast Money? at Motley Fool |
| 15-Jan-13 02:05PM | Why Derma Sciences Is Poised to Pull Back at Motley Fool |
| 01:58PM | LabCorp Remains at Neutral Zacks |
| 12:48PM | Quest Diagnostics Remains at Neutral Zacks |
| 14-Jan-13 09:06AM | 1 Reason to Expect Big Things from Derma Sciences at Motley Fool |
| 21-Dec-12 04:23PM | DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 11-Dec-12 05:22PM | Derma Sciences Closes $36.4 Million Underwritten Public Offering of Common Stock, Including Full Over-Allotment Business Wire |
| 10-Dec-12 04:23PM | DERMA SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online |
| 07-Dec-12 06:05PM | Nasdaq stocks posting largest volume increases AP |
| 04:36PM | DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit EDGAR Online |
| 06-Dec-12 07:10PM | Derma Sciences Prices Offering, Pfizer Partners with Protalix: Healthcare Business Wrap at Wall St. Cheat Sheet +5.61% |
| 06:07PM | Nasdaq stocks posting largest volume increases AP |
| 05:50PM | Derma Sciences Prices Offering, Pfizer Partners with Protalix: Healthcare Business Wrap at Wall St. Cheat Sheet |
| 09:23AM | InPlay from Briefing.com Briefing.com |
| 09:07AM | Derma Sciences 3.062M share Secondary priced at $10.34 theflyonthewall.com |
| 09:04AM | InPlay: Derma Sciences priced an underwritten public offering of 3,062,000 shares of common stock at a price to the public of $10.34 per share Briefing.com |
| 09:00AM | Derma Sciences Announces Pricing of Underwritten Public Offering of Common Stock Business Wire |
| 05-Dec-12 04:07PM | InPlay from Briefing.com Briefing.com -7.51% |
| 04:04PM | InPlay: Derma Sciences announce commencement of public offernig of common stock, size not disclosed Briefing.com |
| 04:04PM | Derma Sciences Announces Commencement of Public Offering of Common Stock Business Wire |
| 04-Dec-12 08:47AM | Zacks #1 Rank Additions for Tuesday Zacks |
| 30-Nov-12 02:29PM | Derma Sciences to Present at Two Upcoming Conferences Business Wire |
| 29-Nov-12 08:10AM | Zacks #1 Rank Additions for Thursday Zacks |
| 20-Nov-12 08:00AM | Derma Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference Business Wire |
| 04:07AM | Zacks #1 Rank Additions for Tuesday Zacks |
| 17-Nov-12 01:04PM | DERMA SCIENCES, INC. Financials EDGAR Online Financials |
| 14-Nov-12 05:20AM | If Derma Can Weather The Storm Of Competition, Then Good Things May Be Ahead at Seeking Alpha |
| 13-Nov-12 09:30AM | New Star Analyst Rankings for Derma Sciences, Inc. StarMine |
| 12-Nov-12 12:00PM | Derma Sciences Earnings Call scheduled for 12:00 pm ET today CCBN |
| 11:00AM | Derma Sciences Earnings Call scheduled for 11:00 am ET today CCBN |
| 10:16AM | Derma Sciences to Present at the Lazard Capital Markets 9th Annual Healthcare Conference Business Wire |
| 07:30AM | Derma Sciences Reports Third Quarter 2012 Financial Results Business Wire |
| 07:07AM | Q3 2012 Derma Sciences Earnings Release - Time Not Supplied CCBN |
| 09-Nov-12 04:14PM | DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 05-Nov-12 02:13PM | Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 12th Business Wire |
| 10:50AM | 1-Star Stocks Poised to Plunge: Derma Sciences? at Motley Fool |
| 22-Oct-12 07:30AM | InPlay: Derma Sciences on track to begin phase 3 program with DSC127 in December following meeting with FDA Briefing.com |
| 07:30AM | Derma Sciences on Track to Begin Phase 3 Program with DSC127 in December Following Meeting with FDA Business Wire |
| 20-Sep-12 04:47PM | DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights EDGAR Online |
| 04:21PM | InPlay: Derma Sciences announced pilot study in patients with head and neck cancer finds that Derma Sciences' MEDIHONEY reduces hospital stays in the U.K. Briefing.com |
| 04:02PM | Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences MEDIHONEY® Reduces Hospital Stays in the U.K. Business Wire |
| 06-Sep-12 07:30AM | Derma Sciences Launches MEDIHONEY® HCS in the U.S. Business Wire |
| 05-Sep-12 12:40PM | Derma Sciences to Present at the Rodman and Renshaw Annual Global Investment Conference Business Wire |
| 27-Aug-12 11:48AM | 4 High-Liquid Healthcare Stocks Strongly Favored By Analysts at Seeking Alpha |
| 18-Aug-12 01:04PM | DERMA SCIENCES, INC. Financials EDGAR Online Financials |
| 15-Aug-12 01:49PM | Wall Street Transcript Interview with Edward J. Quilty, CEO of Derma Sciences (DSCI) Wall Street Transcript |
| 09:41AM | New Star Analyst Rankings for Derma Sciences, Inc. StarMine |
| 14-Aug-12 03:43PM | Derma Sciences takes bigger 2Q loss as costs rise AP |
| 11:00AM | Derma Sciences Earnings Call scheduled for 11:00 am ET today CCBN |
| 10:46AM | Derma Sciences Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:37AM | Derma Sciences Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:30AM | Derma Sciences Reports Second Quarter 2012 Financial Results Business Wire |
| 07:07AM | Q2 2012 Derma Sciences Earnings Release - Before Market Open CCBN |
| 13-Aug-12 05:20PM | DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09-Aug-12 01:22PM | Derma Sciences to Present at the Canaccord Genuity Annual Growth Conference Business Wire |
| 06-Aug-12 04:37PM | Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 14th Business Wire |
| 24-Jul-12 02:50AM | 5 Highly Liquid Medical Device Stocks With Encouraging Receivable Trends at Seeking Alpha |
